In this edition of Daily Dose, Dr. Lacy Anderson answers a viewer's question about what discounts are available for weight ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are ...

As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

And people gain the weight back when they come off it.” Costs for five of the GLP-1 drugs — Ozempic, Mounjaro, Wegovy, Zepbound, and Saxenda — topped $300 million for Boston-based Blue Cross ...